Skip to main content
Article thumbnail
Location of Repository

A three species model to simulate application of\ud hyperbaric oxygen therapy to chronic wounds

By Jennifer Flegg, Sean McElwain, Helen M. Byrne and Ian W. Turner


Chronic wounds are a significant socioeconomic problem for governments worldwide. Approximately 15% of people who suffer from diabetes will experience a lower-limb ulcer at some stage of their lives, and 24% of these wounds will ultimately result in amputation of the lower limb. Hyperbaric Oxygen Therapy (HBOT) has been shown to aid the healing of chronic wounds; however, the causal reasons for the improved healing remain unclear and hence current HBOT protocols remain empirical. Here we develop a three-species mathematical model of wound healing that is used to simulate the application of hyperbaric oxygen therapy in the treatment of wounds. Based on our modelling, we predict that intermittent HBOT will assist chronic wound healing while normobaric oxygen is ineffective in treating such wounds. Furthermore, treatment should continue until healing is complete, and HBOT will not stimulate healing under all circumstances, leading us to conclude that finding the right protocol for an individual patient is crucial if HBOT is to be effective. We provide constraints that depend on the model parameters for the range of HBOT protocols that will stimulate healing. More specifically, we predict that patients with a poor arterial supply of oxygen, high consumption of oxygen by the wound tissue, chronically hypoxic wounds, and/or a dysfunctional endothelial cell response to oxygen are at risk of nonresponsiveness to HBOT. The work of this paper can, in some way, highlight which patients are most likely to respond well to HBOT (for example, those with a good arterial supply), and thus has the potential to assist in improving both the success rate and hence the costeffectiveness of this therapy

Topics: 111208 Radiation Therapy, 019900 OTHER MATHEMATICAL SCIENCES, 060100 BIOCHEMISTRY AND CELL BIOLOGY, Hyperbaric Oxygen Therapy, HBOT, Chronic wounds
Publisher: PLoS
Year: 2009
DOI identifier: 10.1371/journal.pcbi.1000451
OAI identifier:

Suggested articles


  1. (2002). A
  2. (2005). A deterministic model of growth factorinduced angiogenesis.
  3. (2003). A mathematical model for the role of cell signal transduction in the initiation and inhibition of angiogenesis.
  4. (2000). A mathematical model for the roles of pericytes and macrophages in the initiation of angiogenesis. I. the role of protease inhibitors in preventing angiogenesis.
  5. (1985). A mathematical model of tumour-induced capillary growth.
  6. (1995). A mechanochemical model for adult dermal wound contraction and the permanence of the contracted tissue displacement profile.
  7. (1996). A model of wound-healing angiogenesis in soft tissue.
  8. (2005). A multiple scale model for tumor growth.
  9. (2008). A simple mechanistic model of sprout spacing in tumour-associated angiogenesis.
  10. (2001). A theoretical model for oxygen transport in skeletal muscle under conditions of high oxygen demand.
  11. (2008). A theoretical study of the response of vascular tumours to different types of chemotherapy.
  12. (2004). Advances in the treatment of the diabetic foot: is there a role for adjunctive hyperbaric oxygen therapy.
  13. (1994). American Diabetes Association: Consensus Development Conference on Diabetic Foot Wound Care. In: Diabetes Care.
  14. (1991). Analysis of the roles of microvessel endothelial cell random motility and chemotaxis in angiogenesis.
  15. (2005). Angiogenesis, vasculogenesis, and induction of healing in chronic wounds.
  16. (2002). Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.
  17. (1982). Blood flow in the diabetic neuropathic foot.
  18. (2000). Causes and effects of the chronic inflammation in venous leg ulcers.
  19. (1997). Cell response to hyperbaric oxygen treatment.
  20. (1990). Chemotaxis of human microvessel endothelial cells in response to acidic fibroblast growth factor.
  21. (2009). Computational approaches to solving equations arising from wound healing.
  22. (2004). Continuous measurements of cerebral tissue oxygen pressure during hyperbaric oxygenation – HBO effects on brain edema and necrosis after severe brain trauma in rabbits.
  23. (1992). Continuum model of fibroblast-driven wound contraction: inflammation-mediation.
  24. (1994). Definitions and guidelines for assessment of wounds and evaluation of healing.
  25. (2006). Desmouliere A
  26. (1996). Differential effects of oxygen on human dermal fibroblasts: acute versus chronic hypoxia. Wound Repair and Regeneration
  27. (2002). Early biochemical and histological changes during hyperbaric or normobaric reoxygenation after in vitro ischaemia in primary corticoencephalic cell cultures of rats.
  28. (1999). Effect of hyperbaric oxygen on human skin cells in culture and in human dermal and skin equivalents. Wound Repair and Regeneration
  29. (2006). Effects of hyperbaric oxygen on inflammatory response to wound and trauma: possible mechanism of action.
  30. (1996). Explicit solutions of a simplified model of capillary sprout growth during tumour angiogenesis.
  31. (2003). Franek A
  32. (1983). Growth and metabolism in mycelial fungi.
  33. (2002). Handbook of linear partial differential equations for engineers and scientists Chapman & Hall/CRC.
  34. (1983). Harris A
  35. (2001). HIF-1 expression in healing wounds: HIF-1alpha induction in primary inflammatory cells by TNF-alpha.
  36. (1984). High resolution schemes using flux limiters for hyperbolic conservation laws.
  37. (1994). Hyperbaric oxygen reduced size of chronic leg ulcers: a randomised double-blind study.
  38. (2001). Hyperbaric oxygen therapy and mandibular osteoradionecrosis: a retrospective study and analysis of treatment outcomes.
  39. (1993). Hyperbaric oxygen therapy in sports injuries.
  40. (2008). Hyperbaric oxygen therapy: types of injury and number of sessions–a review of 1506 cases.
  41. (2003). Hyperbaric oxygen treatment protocols for mandibular osteoradionecrosis. Undersea Hyperb Med 30: 175–179.
  42. (2004). Hyperbaric oxygen: its uses, mechanisms of action and outcomes.
  43. (2004). Hyperbaric oxygenation and wound healing.
  44. (2002). Hyperbaric Surgery, Best Publishing Company, chapter 12: Hyperbaric oxygen therapy in the management of non-healing wounds.
  45. (2005). Infection and the chronic wound: a focus on silver.
  46. (2002). Investigating a simple model of cutaneous wound healing angiogenesis.
  47. (2001). Mathematical modeling of capillary formation and development in tumor angiogenesis: penetration into the stroma.
  48. (2001). Mathematical modeling of the onset of capillary formation initiating angiogenesis.
  49. (2004). Mathematical modeling of tumorinduced angiogenesis.
  50. (2000). Mathematical modelling of angiogenesis in wound healing: comparison of theory and experiment.
  51. (2002). Mathematical modelling of flow through vascular networks: implications for tumour-induced angiogenesis and chemotherapy strategies.
  52. (2002). Mathematical modelling of tumour angiogenesis and the action of angiostatin as a protease inhibitor.
  53. (1995). Mathematical models for dermal wound healing: wound contraction and scar formation.
  54. (2003). Mathematical models of cell colonization of uniformly growing domains.
  55. (2000). Measurement of the extracellular volume of human melanoma xenografts by contrast enhanced magnetic resonance imaging.
  56. (1984). Mechanisms of neovascularization. Vascular sprouting can occur without proliferation of endothelial cells.
  57. (1988). Mechanochemical models for generating biological pattern and form in development.
  58. (2001). Microenvironment influence on macrophage regulation of angiogenesis in wounds and malignant tumors.
  59. (1991). Migration of individual microvessel endothelial cells: stochastic model and parameter measurement.
  60. (2002). Modelling macrophage infiltration into avascular tumours.
  61. (2005). Modelling oxygen diffusion and cell growth in a porous, vascularising scaffold for soft tissue engineering applications.
  62. (2006). Modelling the response of vascular tumours to chemotherapy: A multiscale approach.
  63. (2007). Modelling the role of angiogenesis and vasculogenesis in solid tumour growth.
  64. (2007). Multi-scale modelling of a wound-healing cell migration assay.
  65. (2006). Multiscale modelling of tumour growth and therapy: the influence of vessel normalisation on chemotherapy.
  66. (2005). Nonlinear hehaviors of capillary formation in a deterministic angiogenesis model.
  67. (1999). Numerical aspects of discrete and continuum hybrid models in cell biology.
  68. (1963). Observations on healing tissue: a combined light and electron microscopic investigation.
  69. (1996). On the role of angiogenesis in wound healing.
  70. (1990). Oxygen and wound healing.
  71. (1966). Oxygen consumption rate of tissue measured by a micropolarographic method.
  72. (2004). Oxygen in wound healing - more than a nutrient.
  73. (1983). Oxygen tension regulates the expression of angiogenesis factor by macrophages.
  74. (1999). Physiology of hyperbaric hyperoxia.
  75. (2006). Recent advances and emerging treatments.
  76. (1998). Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor b-1.
  77. (1981). Regulation of wound-healing angiogenesis -effect of oxygen gradients and inspired oxygen concentration.
  78. (2005). Seekamp A
  79. (2006). Stem cell mobilization by hyperbaric oxygen.
  80. (2000). Systemic hyperbaric oxygen therapy: lower-extremity wound healing and the diabetic foot.
  81. (1995). The pathophysiology of angiogenesis.
  82. (2008). The role of vascular endothelial growth factor in wound healing.
  83. (2008). The use of hyperbaric oxygen therapy to treat chronic wounds: a review. Wound Repair and Regeneration
  84. (2006). Time course analysis of hypoxia, granulation tissue and blood vessel growth, and remodeling in healing rat cutaneous incisional primary intention wounds.
  85. (1985). Tissue oxygen measurements with respect to soft tissue wound healing with normobaric and hyperbaric oxygen.
  86. (2008). Topical oxygen therapy induces vascular endothelial growth factor expression and improves closure of clinically presented chronic wounds.
  87. (2004). Treatment of venous leg ulcers with Dermagraft.
  88. (2002). Using hyperbaric oxygen to treat diabetic foot ulcers: safety and effectiveness.
  89. (2008). Wound angiogenesis as a function of tissue oxygen tension: a mathematical model.
  90. (2004). Wound healing: an overview of acute, fibrotic and delayed healing.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.